Share on Facebook. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Rheumatoid arthritis (RA) is currently diagnosed and treated ...

Please provide your email address to receive an email when new articles are posted on . As highlighted in recent advances in rheumatoid arthritis pathogenesis, researchers’ understanding of the ...

In a review published in the Rheumatology Advances in Practice journal, researchers analyzed data on the association between intestinal microbiome dysbiosis and rheumatoid arthritis (RA). Study: The ...

A comprehensive, multi-phase investigation published in Advanced Science suggests that the amino acid tryptophan (Trp) may be a key determinant of therapeutic response to conventional synthetic ...

Rheumatoid arthritis is one of the most common immune-mediated diseases. Its primary manifestation is inflammatory arthritis characterized by symmetric, polyarticular pain and swelling, typically ...

Recent research explores how gut microbiome imbalances contribute to rheumatoid arthritis, and how dietary interventions could be key to reducing inflammation and improving patient outcomes. Study: ...

With the discovery of autoantibodies and other risk factors for rheumatoid arthritis (RA), researchers developed clinical trials to see whether the disease can be prevented entirely. In the past 10 ...

Researchers from OU identified a protein complex involved in the pathogenesis of rheumatoid arthritis. They also show that celastrol, the active compound of a medicinal herb, blocks the progression of ...

The cytokine interleukin-6 is involved in the pathogenesis of rheumatoid arthritis. Olokizumab, a humanized monoclonal antibody targeting the interleukin-6 cytokine directly, is being tested for the ...